Relationship between nutritional treatment compliance and nutritional status improvements in patients with gastrointestinal impairment taking an oral peptide based supplement
Metadata
Show full item recordAuthor
Fernández Soto, María LuisaEditorial
Elsevier
Date
2022-05-04Referencia bibliográfica
Jose A. Lopez-Medina MD, PHD a, Cristobal Lopez-Rodriguez b, María A. Estornell-Gualde MDc, Laura Rey-Fernández b, Silvia Gomez-Senent MDd, Clara Joaquín-Ortiz MDe, M. Luisa Fernández-Soto MDf, Roberto Hurtado-García MDg, Margarita Martín-Martín PHDh, Ana Barrera-Martín MSc, MDi, M. Teresa Vitales-Farrero j, Antonio J. Martínez-Ortega MD, PHDk, María Blanca-Martínez-Barbeito MDl, Bego~na Vazquez-Vizcaíno MDm, Clara Tasende-Fernandez MD, PHD n, M. Angeles Penacho-Lazaro MDo, Esther Jorda-Sorolla MDp, Rebeca Sanchez-Sanchez MDm, Laura Díaz-Gomez MDq, Sergio Baos-Fernandez r, German Guzman-Rolo MDs,*, María D. Ballesteros-Pomar MD, PHD. Nutrition 102 (2022) 111734.t
Sponsorship
Abbott NutritionAbstract
Objectives: Compliance in outpatients with gastrointestinal (GI) malabsorption is key in nutritional treatment.
The objective of this study was to assess compliance in patients with GI impairment and malnutrition
taking a high-calorie, high-protein, peptide-based oral nutritional supplement (ONS-PBD).
Methods: A prospective, multicenter, observational study was conducted in 19 medical sites in Spain where
ONS-PBD were prescribed as standard of care. Patients consumed ONS-PBD daily for 12 wk. Compliance was
calculated as the percentage consumed of the prescribed amount of ONS per day.
Results: A total of 90 adult patients were included in the study, of whom 64 completed the 12-wk regimine.
Mean compliance was 78.8% § 24.5%. Risk of malnutrition decreased in 56.3% of patients at 12 wk, as measured
with the malnutrition universal screening tool. A reduction in abdominal pain was observed and stool consistency improved, with a mean of 54.7% and 27.5%, respectively. Improvements in quality of life and a decrease in percentage of patients with severe functional impairment were observed. Conclusions: These data show that ONS-PBD compliance in malnourished patients with GI symptoms is high, reducing GI symptoms and improving patients’ nutritional status.